X-151623002-C-T
Variant summary
Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BS2
The NM_173493.3(PASD1):c.484C>T(p.Pro162Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000191 in 1,207,203 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 8 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 15/23 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P162R) has been classified as Uncertain significance.
Frequency
Consequence
NM_173493.3 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -4 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000358 AC: 4AN: 111618Hom.: 0 Cov.: 23 show subpopulations
GnomAD2 exomes AF: 0.0000329 AC: 6AN: 182260 AF XY: 0.00 show subpopulations
GnomAD4 exome AF: 0.0000173 AC: 19AN: 1095585Hom.: 0 Cov.: 29 AF XY: 0.0000138 AC XY: 5AN XY: 361183 show subpopulations
GnomAD4 genome AF: 0.0000358 AC: 4AN: 111618Hom.: 0 Cov.: 23 AF XY: 0.0000887 AC XY: 3AN XY: 33810 show subpopulations
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.484C>T (p.P162S) alteration is located in exon 7 (coding exon 6) of the PASD1 gene. This alteration results from a C to T substitution at nucleotide position 484, causing the proline (P) at amino acid position 162 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at